SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 19.73 |
| Enterprise Value ($M) | 24.48 |
| Book Value ($M) | 7.96 |
| Book Value / Share | 0.50 |
| Price / Book | 2.48 |
| NCAV ($M) | -5.45 |
| NCAV / Share | -0.34 |
| Price / NCAV | -3.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.27 |
| Return on Assets (ROA) | -0.20 |
| Return on Equity (ROE) | -0.39 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.22 |
| Current Ratio | 0.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.47 |
| Assets | 14.88 |
| Liabilities | 6.92 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.51 |
| Operating Income | -4.71 |
| Net Income | -4.90 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -1.81 |
| Cash from Investing | 0.00 |
| Cash from Financing | 1.98 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Lind Global Fund II LP | 9.90 | 15.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 116,859 | 429,505 | 27.21 | |
| 41,915 | 619,031 | 6.77 | |
| 130,273 | 700,700 | 18.59 | |
| 105,184 | 366,951 | 28.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABEO – Abeona Therapeutics Inc. | ACB – Aurora Cannabis Inc. |
| ACHV – Achieve Life Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io